SQZ BIOTECHNOLOGIES COMPANY Increase (Decrease) in Other Operating Liabilities
SQZ BIOTECHNOLOGIES COMPANY reported Increase (Decrease) in Other Operating Liabilities of -$175.00 thousand for the 12-month period ending 2021-12-31, per its 10-K filed 2023-03-22.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherOperatingLiabilities · last filed 2023-03-22
- SQZ BIOTECHNOLOGIES COMPANY increase (decrease) in other operating liabilities for the quarter ending 2020-12-31 was -$802.00K.
- SQZ BIOTECHNOLOGIES COMPANY increase (decrease) in other operating liabilities for the quarter ending 2020-09-30 was $159.00K.
- SQZ BIOTECHNOLOGIES COMPANY increase (decrease) in other operating liabilities for the quarter ending 2019-12-31 was -$306.00K.
- SQZ BIOTECHNOLOGIES COMPANY increase (decrease) in other operating liabilities for fiscal 2021 was -$175.00K.
- SQZ BIOTECHNOLOGIES COMPANY increase (decrease) in other operating liabilities for fiscal 2020 was -$535.00K.
- SQZ BIOTECHNOLOGIES COMPANY increase (decrease) in other operating liabilities for fiscal 2019 was -$117.00K.
| Period end | Increase (Decrease) in Other Operating Liabilities 3 month | Increase (Decrease) in Other Operating Liabilities 6 month | Increase (Decrease) in Other Operating Liabilities 9 month | Increase (Decrease) in Other Operating Liabilities 12 month |
|---|---|---|---|---|
| 2021-12-31 | -$175.00K 10-K · filed 2023-03-22 | |||
| 2020-12-31 | -$802.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-16 | -$643.00K derived: sum of 2 quarters · filed 2022-03-16 | -$535.00K 10-K · filed 2022-03-16 | |
| 2020-09-30 | $159.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $267.00K 10-Q · filed 2021-11-10 | ||
| 2020-06-30 | $108.00K 10-Q · filed 2021-08-04 | |||
| 2019-12-31 | -$306.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-18 | -$117.00K 10-K · filed 2021-03-18 | ||
| 2019-09-30 | $189.00K 10-Q · filed 2020-12-10 |